leisure time -WSS

leisure time

author：leisure time 2025-10-04 11:50:23 - browse：26

Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal — Adobe

A deal is never really done until it’s done.

On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Lung cancer screening guidelines updated for cigarette smokers

hotspot

WSS

After Sarepta trial failure, Duchenne families brace for more debate

Coloradans with cystic fibrosis could lose access to Trikafta

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Live blog: Hearing on CRISPR

The drug industry has found itself all alone in Washington

Explaining an after

explore

leisure time

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Life sciences investors close nearly $6 billion in new funds

In Memoriam: Notable people who died in 2023

Infant mortality in U.S. rose last year for first time in decades: CDC

Activists slam private health insurers over coverage restrictions

Travis Kelce and the trap of celebrity vaccine endorsements

After affirmative action ruling, medical educators look to 'holistic review'

Headspace, Meta partner to launch VR meditation app for Quest

State Dept. review finds Biden bears some blame for Afghanistan failures

Precocious puberty in girls comes with mental health risks

leisure time

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

The drug industry has found itself all alone in Washington

Amylyx ALS drug fails large clinical trial

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Prime Medicine says its gene editing passes test in monkeys

The health care issue Democrats can’t solve: hospital reform

hotspot

hotspot

explore

focus